Cover Image
市場調查報告書

流鼻血:全球臨床實驗趨勢

Epistaxis Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 235291
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
流鼻血:全球臨床實驗趨勢 Epistaxis Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月16日 內容資訊: 英文 64 Pages
簡介

本報告提供流鼻血臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 流鼻血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:耳鼻喉科疾病治療藥臨床實驗上流鼻血的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:耳鼻喉科疾病治療藥臨床實驗上流鼻血的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

流鼻血臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Troikaa Pharmaceuticals Ltd.
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Hospices Civils de Lyon
    • University of California, San Diego
    • Centre Hospitalier Universitaire de Caen
    • IRCCS Policlinico San Matteo
    • Mayo Clinic
    • National Center for Research Resources
    • Ottawa Hospital Research Institute
    • Stanford University
    • Tabriz University of Medical Sciences
    • University of Kansas

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2730CTIDB

GlobalData's clinical trial report, "Epistaxis Global Clinical Trials Review, H1, 2015" provides an overview of Epistaxis clinical trials scenario. This report provides top line data relating to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Epistaxis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Epistaxis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Epistaxis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Troikaa Pharmaceuticals Ltd.
      • Clinical Trial Overview of Troikaa Pharmaceuticals Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Hospices Civils de Lyon
      • Clinical Trial Overview of Hospices Civils de Lyon
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • Centre Hospitalier Universitaire de Caen
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Caen
      • IRCCS Policlinico San Matteo
      • Clinical Trial Overview of IRCCS Policlinico San Matteo
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • University of Kansas
      • Clinical Trial Overview of University of Kansas
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Epistaxis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015*
  • Epistaxis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Epistaxis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015*
  • Epistaxis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Epistaxis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Epistaxis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Epistaxis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Epistaxis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Caen, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015*
  • Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kansas, 2015*

List of Figures

  • Epistaxis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Epistaxis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015*
  • Epistaxis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Epistaxis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Epistaxis to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015*
  • Epistaxis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Epistaxis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Epistaxis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Epistaxis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Epistaxis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top